Cargando…

Endostatin and Vascular Endothelial Growth Factor-A(165)b May Contribute to Classification of Pulmonary Hypertension

Background: Pulmonary hypertension (PH) is characterized by dysregulation of small pulmonary arteries. In addition to endostatin (ES), placenta growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A), and the anti-angiogenesis isoform of VEGF-A (VEGF-A(165)b) are associated with PH. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adachi, Shiro, Kikuchi, Ryosuke, Shimokata, Shigetake, Suzuki, Atsuo, Yoshida, Masahiro, Imai, Ryo, Nakano, Yoshihisa, Kondo, Takahisa, Murohara, Toyoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2021
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956881/ https://www.ncbi.nlm.nih.gov/pubmed/33738349 http://dx.doi.org/10.1253/circrep.CR-20-0096

Ejemplares similares

＜Editors’ Choice＞ Differential effects of combination therapy on the components of the risk stratification table in patients with idiopathic or heritable pulmonary arterial hypertension in a Japanese population
por: Yoshida, Masahiro, et al.
Publicado: (2021)

Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth
por: Adachi, Shiro, et al.
Publicado: (2020)

Left ventricular end-diastolic dimension and septal e′ are predictors of cardiac index at rest, while tricuspid annular plane systolic excursion is a predictor of peak oxygen uptake in patients with pulmonary hypertension
por: Nakano, Yoshihisa, et al.
Publicado: (2017)

Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension
por: Kamimura, Yoshihiro, et al.
Publicado: (2018)

Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity
por: Hirashiki, Akihiro, et al.
Publicado: (2019)

Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension
por: Hirashiki, Akihiro, et al.
Publicado: (2017)

Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension　― Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE) ―
por: Hirashiki, Akihiro, et al.
Publicado: (2019)

Pulmonary tumor thrombotic microangiopathy with thrombus in pulmonary artery caused by diffuse sclerosing variant of thyroid papillary adenocarcinoma: A case report
por: Yoshida, Masahiro, et al.
Publicado: (2022)

Safe and successful transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension treated with triple combination therapy
por: Adachi, Shiro, et al.
Publicado: (2022)

Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy
por: Yasuda, Kenichiro, et al.
Publicado: (2022)

Pulmonary Hypertension: Diagnosis, Management, and Treatment
por: Kondo, Takahisa, et al.
Publicado: (2019)

Option of Using Peripherally Inserted Central Catheters in Elderly Patients With Dementia: An Observational Study
por: Nakano, Yoshihisa, et al.
Publicado: (2020)

Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy
por: Hirashiki, Akihiro, et al.
Publicado: (2016)

Left main coronary artery compression by a dilated main pulmonary artery and left coronary sinus of Valsalva aneurysm in a patient with heritable pulmonary arterial hypertension and FLNA mutation
por: Hirashiki, Akihiro, et al.
Publicado: (2017)

Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005)

Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
por: Wang, Shan, et al.
Publicado: (2016)

A multicenter prospective cohort study to develop frailty-based prognostic criteria in heart failure patients (FLAGSHIP): rationale and design
por: Yamada, Sumio, et al.
Publicado: (2018)

Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)
por: Yamada, Sumio, et al.
Publicado: (2021)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

A new path for endostatin
por: Dove, Alan W.
Publicado: (2002)

Dynamics of angiogenesis in ischemic areas of the infarcted heart
por: Kobayashi, Koichi, et al.
Publicado: (2017)

Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients
por: Mårtensson, Johan, et al.
Publicado: (2016)

Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model
por: Ge, Hong-yan, et al.
Publicado: (2011)

FRI165 BIUXX
por: Haider, Adnan, et al.
Publicado: (2023)

Therapeutic angiogenesis using autologous adipose-derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study
por: Katagiri, Takeshi, et al.
Publicado: (2020)

Endostatin expression in pancreatic tissue is modulated by elastase
por: Brammer, R D, et al.
Publicado: (2005)

Endostatin is a potential inhibitor of Wnt signaling
por: Hanai, Jun-ichi, et al.
Publicado: (2002)

Exercise increases endostatin in circulation of healthy volunteers
por: Gu, Jian-Wei, et al.
Publicado: (2004)

Endostatin inhibits bradykinin-induced cardiac contraction
por: YASUDA, Jumpei, et al.
Publicado: (2015)

Endostatin as a Biomarker of Basement Membrane Degradation
por: Sato, Yasufumi
Publicado: (2017)

Adolescent Kawasaki disease shock syndrome with inflammatory cell infiltration into the myocardium: a case report
por: Sugiura, Yuki, et al.
Publicado: (2020)

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
por: Gu, Yan-hui, et al.
Publicado: (2021)

Extension of the experiment T 165 + T 168
por: CERN. Geneva. Track Chamber Committee
Publicado: (1972)

165th RB Meeting
por: CERN. Geneva. Research Board
Publicado: (2003)

At the cryogenic laboratory, Bld. 165
Publicado: (1978)

At the cryogenic laboratory, Bld. 165
Publicado: (1978)

Subject index for volume 165
Publicado: (1988)

Therapeutic Angiogenesis with Somatic Stem Cell Transplantation
por: Murohara, Toyoaki
Publicado: (2019)

Endostatin and anastellin inhibit distinct aspects of the angiogenic process
por: Neskey, David M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gqvb4p3b1ilm99cdvnnlshg52l